Pathogenesis of Bone Alterations in Gaucher Disease: The Role of Immune System

被引:28
|
作者
Marcos Mucci, Juan
Rozenfeld, Paula [1 ]
机构
[1] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, IIFP, RA-1900 La Plata, Buenos Aires, Argentina
关键词
ENZYME REPLACEMENT THERAPY; LYSOSOMAL STORAGE DISORDERS; SOLUBLE RECEPTOR ACTIVATOR; KAPPA-B LIGAND; IN-VITRO MODEL; T-CELLS; RHEUMATOID-ARTHRITIS; ELEVATED LEVELS; TYPE-1; GLUCOCEREBROSIDASE;
D O I
10.1155/2015/192761
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Gaucher, the most prevalent lysosomal disorder, is an autosomal recessive inherited disorder due to a deficiency of glucocerebrosidase. Glucocerebrosidase deficiency leads to the accumulation of glucosylceramide primarily in cells of mononuclear-macrophage lineage. Clinical alterations are visceral, hematological, and skeletal. Bone disorder in Gaucher disease produces defects on bone metabolism and structure and patients suffer from bone pain and crisis. Skeletal problems include osteopenia, osteoporosis, osteolytic lesions, and osteonecrosis. On the other hand a chronic stimulation of the immune systemis a well-accepted hallmark in this disease. In this review we summarize the latest findings in the mechanisms leading to the bone pathology in Gaucher disease in relationship with the proinflammatory state.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Gaucher Disease and Bone Manifestations
    Marcucci, Gemma
    Zimran, Ari
    Bembi, Bruno
    Kanis, John
    Reginster, Jean-Yves
    Rizzoli, Rene
    Cooper, Cyrus
    Brandi, Maria Luisa
    CALCIFIED TISSUE INTERNATIONAL, 2014, 95 (06) : 477 - 494
  • [32] Bone pathology of Gaucher disease
    Lopez-Herce Cid, J. A.
    REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2010, 2 (02) : 5 - 6
  • [33] BONE LOSS IN GAUCHER DISEASE
    WATTS, RWE
    REEVE, J
    MEUNIER, PJ
    SPELLACY, E
    KLENERMAN, L
    HESP, R
    CLINICAL SCIENCE, 1985, 69 : P46 - P46
  • [34] Bone crises in Gaucher disease
    Cohen, IJ
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (11): : 838 - 839
  • [35] The mucosal immune system in the pathogenesis of liver disease
    Eksteen, B.
    Adams, D. H.
    LIVER CIRRHOSIS: FROM PATHOPHYSIOLOGY TO DISEASE MANAGEMENT, 2008, 162 : 11 - 18
  • [36] BONE AFECTATION IN TYPE 1 GAUCHER DISEASE: ROLE OF PROIMMFLAMMATORY CYTOKINES
    Giraldo, P.
    Gervas, J.
    Quintana, L.
    Pocovi, M.
    Giraldo, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 485 - 485
  • [37] Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literature
    Mikosch, P.
    Kohlfuerst, S.
    Gallowitsch, H. J.
    Kresnik, E.
    Lind, P.
    Mehta, A. B.
    Hughes, D. A.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2008, 47 (06): : 239 - 247
  • [38] Gaucher's disease with valve calcification: Possible role of Gaucher cells, bone matrix proteins and integrins
    Veinot, JP
    Elstein, D
    Hanania, D
    Abrahamov, A
    Srivatsa, S
    Zimran, A
    CANADIAN JOURNAL OF CARDIOLOGY, 1999, 15 (02) : 211 - 216
  • [39] Role of the immune system in bone loss
    Goldring, SR
    BONE, 2005, 36 : S111 - S112
  • [40] Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses
    Cox, TM
    JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 : 106 - 121